MDXG MiMedx
- 6.270
- +0.025+0.40%
MiMedx News
Analysts Are Bullish on These Healthcare Stocks: Cerus (CERS), MiMedx Group (MDXG)
MIMEDX to Host First Quarter 2024 Operating and Financial Results Conference Call on April 30
MARIETTA, Ga., April 16, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today announced that it will report its operating and financial results for the first
MiMedx Group, Inc.'s (NASDAQ:MDXG) Prospects Need A Boost To Lift Shares
MiMedx Group, Inc.'s (NASDAQ:MDXG) price-to-sales (or "P/S") ratio of 3x might make it look like a strong buy right now compared to the Biotechs industry in the United States, where around half of the
MiMedx Group (MDXG) Receives a Buy From Northland Securities
Analysts Conflicted on These Healthcare Names: Cellectar Biosciences (CLRB), MiMedx Group (MDXG) and Marinus (MRNS)
Merck, Cintas Rise; GameStop, MiMedx Fall, Wednesday, 3/27/2024
MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit
MiMedx Group said federal regulators are sticking to their position that its Axiofill product doesn't meet regulatory requirements for a certain classification sought by the company.
The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Product
The FDA Issued Determination Letter For Mimedx's Request For Designation Noting Axiofill Does Not Meet Regulatory Classification Requirements Of A Human Cell, Tissue, Or Cellular Or Tissue-based Produ
MiMedx Group Reiterates Expectations for 2024 Net Sales Percentage Growth in the Low Double Digits >MDXG
MiMedx Group Reiterates Expectations for 2024 Net Sales Percentage Growth in the Low Double Digits >MDXG
Is MiMedx Group (NASDAQ:MDXG) Using Too Much Debt?
Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that debt - which is usually involved in bankruptcies - is a very important factor, when
Investing in MiMedx Group (NASDAQ:MDXG) a Year Ago Would Have Delivered You a 138% Gain
Northland Securities Keeps Their Buy Rating on MiMedx Group (MDXG)
TELA Bio Launches Liquifix Surgical Devices in the U.S.
Analysts Conflicted on These Healthcare Names: Diamedica Therapeutics (DMAC), Design Therapeutics (DSGN) and MiMedx Group (MDXG)
Tela Bio Announced Sale Of Distribution Rights Related To NIVIS Fibrillar Collagen Pack To MiMedx For Initial $5M Payment And Additional Future Payments Of $3M-$7M Based On Net Sales Of NIVIS Over The Next Two Years
Tela Bio Announced Sale Of Distribution Rights Related To NIVIS Fibrillar Collagen Pack To MiMedx For Initial $5M Payment And Additional Future Payments Of $3M-$7M Based On Net Sales Of NIVIS Over The
Press Release: TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX TELA Bio to receive at least $8 million and up to $12 million in total consideration MALVERN, Pa., March 20, 2024 (GLO
MIMEDX Expands Portfolio With Fibrillar Collagen Wound Dressing
MARIETTA, Ga., March 20, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (NASDAQ:MDXG) ("MIMEDX" or the "Company") today announced that it has entered into an agreement with TELA Bio, Inc. to obtain exclusive rights to its
MiMedx Launches E-Commerce Platform
MiMedx (MDXG) said Wednesday it has launched MIMEDX Connect, an online product ordering and account management portal. The portal allows clients to place orders, pay invoices, file insurance verificat
MIMEDX Introduces E-Commerce and Account Management Platform
Designed to Streamline Ordering, Payment Processing, and Reimbursement SubmissionsMARIETTA, Ga., March 13, 2024 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") toda
MiMedx Group Initiated at Buy by Lake Street
MiMedx Group Initiated at Buy by Lake Street
Analysis
Price Target
No Data
